Propanc Biopharma, Inc.
PPCB · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Zelinger Josef: Form 4
Insider disclosure · Filed · Report period 05 Jul 2023
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001517681 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PPCB on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 302/6 Butler Street, Camberwell, Victoria, Australia, 3124
- Incorporated in
- DE
- Fiscal year end
- 30 June
- Former names on EDGAR
- Propanc Health Group Corp (to 05 Apr 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields